Literature DB >> 18304698

Amyloid precursor protein increases cortical neuron size in transgenic mice.

Esther S Oh1, Alena V Savonenko, Julie F King, Stina M Fangmark Tucker, Gay L Rudow, Guilian Xu, David R Borchelt, Juan C Troncoso.   

Abstract

The amyloid precursor protein (APP) is the source of beta-amyloid, a pivotal peptide in the pathogenesis of Alzheimer's disease (AD). This study examines the possible effect of APP transgene expression on neuronal size by measuring the volumes of cortical neurons (microm(3)) in transgenic mouse models with familial AD Swedish mutation (APPswe), with or without mutated presenilin1 (PS1dE9), as well as in mice carrying wild-type APP (APPwt). Overexpression of APPswe and APPwt protein, but not of PS1dE9 alone, resulted in a greater percentage of medium-sized neurons and a proportionate decrease in the percentage of small-sized neurons. Our observations indicate that the overexpression of mutant (APPswe) or wild-type APP in transgenic mice is necessary and sufficient for hypertrophy of cortical neurons. This is highly suggestive of a neurotrophic effect and also raises the possibility that the lack of neuronal loss in transgenic mouse models of AD may be attributed to overexpression of APP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304698      PMCID: PMC2796369          DOI: 10.1016/j.neurobiolaging.2007.12.024

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  35 in total

1.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  The amyloid beta protein precursor or proteinase nexin II from mouse is closer related to its human homolog than previously reported.

Authors:  B De Strooper; F Van Leuven; H Van den Berghe
Journal:  Biochim Biophys Acta       Date:  1991-12-02

3.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Steroid-dependent plasticity in the medial amygdala.

Authors:  B M Cooke
Journal:  Neuroscience       Date:  2005-12-05       Impact factor: 3.590

5.  The expression of wild-type human amyloid precursor protein affects the dendritic phenotype of neocortical pyramidal neurons in transgenic mice.

Authors:  Alán Alpár; Uwe Ueberham; Martina K Brückner; Thomas Arendt; Ulrich Gärtner
Journal:  Int J Dev Neurosci       Date:  2005-12-27       Impact factor: 2.457

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 8.  Genetic neurodegenerative diseases: the human illness and transgenic models.

Authors:  D L Price; S S Sisodia; D R Borchelt
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

Review 10.  Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory.

Authors:  Paul R Turner; Kate O'Connor; Warren P Tate; Wickliffe C Abraham
Journal:  Prog Neurobiol       Date:  2003-05       Impact factor: 11.685

View more
  16 in total

Review 1.  An overview of APP processing enzymes and products.

Authors:  Vivian W Chow; Mark P Mattson; Philip C Wong; Marc Gleichmann
Journal:  Neuromolecular Med       Date:  2010-03       Impact factor: 3.843

2.  Large quantities of Abeta peptide are constitutively released during amyloid precursor protein metabolism in vivo and in vitro.

Authors:  Abhay Moghekar; Sneha Rao; Ming Li; Dawn Ruben; Andrew Mammen; Xiaopei Tang; Richard J O'Brien
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

Review 3.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

Review 5.  Amyloid precursor protein processing and Alzheimer's disease.

Authors:  Richard J O'Brien; Philip C Wong
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

Review 6.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

7.  Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults.

Authors:  Dong Woo Kang; Sheng-Min Wang; Yoo Hyun Um; Nak Young Kim; Chang Uk Lee; Hyun Kook Lim
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

8.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

9.  The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.

Authors:  D Iacono; W R Markesbery; M Gross; O Pletnikova; G Rudow; P Zandi; J C Troncoso
Journal:  Neurology       Date:  2009-07-08       Impact factor: 9.910

10.  Impaired structural correlates of memory in Alzheimer's disease mice.

Authors:  Amanpreet Badhwar; Jason P Lerch; Edith Hamel; John G Sled
Journal:  Neuroimage Clin       Date:  2013-09-06       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.